McCarthy Teresa 4
4 · Avidity Biosciences, Inc. · Filed Aug 15, 2025
Insider Transaction Report
Form 4
McCarthy Teresa
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-08-15−10,000→ 100,000 totalExercise: $22.34Exp: 2031-02-01→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2025-08-15$22.34/sh+10,000$223,400→ 107,130 total - Sale
Common Stock
2025-08-15$46.56/sh−10,000$465,632→ 97,130 total
Footnotes (3)
- [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on April 11, 2025.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.36 to $47.50. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares subject to this option award are fully vested and exercisable as of the date hereof.